| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Departments of Pulmonary and Critical Care Medicine [J. C. H., S. Z., S. A. A. C., S. C. E.] and Cancer Biology, and Department of Anatomic Pathology [C. F.], Cleveland Clinic Foundation, Lerner Research Institute, Cleveland, Ohio 44195
Reactive oxygen species (ROS) are important in the initiation and promotion of cells to neoplastic growth. In this context, cigarette smoke exposure, the primary risk factor in lung cancer development, leads to high levels of ROS within the human airway. Although well-equipped with an integrated antioxidant defense system consisting of low-molecular weight antioxidants such as glutathione and intracellular enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase, the lungs are vulnerable to increased endogenous and exogenous oxidative insults. Antioxidants increase in response to oxidative stress and minimize ROS-induced injury in experimental systems, indicating that antioxidant levels may determine whether ROS can initiate lung carcinogenesis. On this basis, we hypothesized that antioxidants would be decreased in lung carcinoma cells as compared with tumor-free adjacent lung tissues. Antioxidant expression was evaluated in 16 lung tumor and 21 tumor-free lung tissues collected between the years 1993 and 2001 from 24 individuals with surgically resectable non-small cell lung cancer, i.e., adenocarcinoma and squamous cell carcinoma. Total SOD activity was increased (P = 0.035), catalase activity decreased (P = 0.002), and glutathione and glutathione peroxidase were similar in tumors compared with tumor-free lung tissues. Alterations in antioxidant activities were attributable to increased manganese SOD and decreased catalase protein and mRNA expression in tumors. Immunohistochemical localization of catalase in the lung revealed decreased or no expression in the tumor cells, although healthy adjacent airway epithelial cells were strongly positive for catalase. Parallel changes in antioxidant activities, protein, and mRNA expression were noted in A549 lung carcinoma cell lines exposed to cytokines (tumor necrosis factor-
, interleukin 1ß, and IFN-
). Thus, inflammation in the lung may contribute to high levels of manganese SOD and decreased catalase, which together may lead to increased hydrogen peroxide intracellularly and create an intracellular environment favorable to DNA damage and the promotion of cancer.
This article has been cited by other articles:
![]() |
A. A. Qutub and A. S. Popel Reactive Oxygen Species Regulate Hypoxia-Inducible Factor 1{alpha} Differentially in Cancer and Ischemia Mol. Cell. Biol., August 15, 2008; 28(16): 5106 - 5119. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Connor, N. Hempel, K. K. Nelson, G. Dabiri, A. Gamarra, J. Belarmino, L. Van De Water, B. M. Mian, and J. A. Melendez Manganese Superoxide Dismutase Enhances the Invasive and Migratory Activity of Tumor Cells Cancer Res., November 1, 2007; 67(21): 10260 - 10267. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Mazzone, J. Hammel, R. Dweik, J. Na, C. Czich, D. Laskowski, and T. Mekhail Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array Thorax, July 1, 2007; 62(7): 565 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Ho, M. Chan-Yeung, S. P. Ho, J. C. Mak, M. S. Ip, G. C. Ooi, M. P. Wong, K. W. Tsang, and W. K. Lam Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma Eur. Respir. J., February 1, 2007; 29(2): 273 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hays, D. Srinivasan, M. L. Witten, D. E. Carter, and R. C. Lantz Arsenic and Cigarette Smoke Synergistically Increase DNA Oxidation in the Lung Toxicol Pathol, June 1, 2006; 34(4): 396 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Peikert, U. Specks, C. Farver, S. C. Erzurum, and S. A.A. Comhair Melanoma Antigen A4 Is Expressed in Non-Small Cell Lung Cancers and Promotes Apoptosis. Cancer Res., May 1, 2006; 66(9): 4693 - 4700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu, L. V. Papp, J. Fang, S. Rodriguez-Nieto, B. Zhivotovsky, and A. Holmgren Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res., April 15, 2006; 66(8): 4410 - 4418. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Masri, S. A. A. Comhair, T. Koeck, W. Xu, A. Janocha, S. Ghosh, R. A. Dweik, J. Golish, M. Kinter, D. J. Stuehr, et al. Abnormalities in Nitric Oxide and Its Derivatives in Lung Cancer Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 597 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Machado, D. Laskowski, O. Deffenderfer, T. Burch, S. Zheng, P. J. Mazzone, T. Mekhail, C. Jennings, J. K. Stoller, J. Pyle, et al. Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1286 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Kinnula, T. Torkkeli, P. Kristo, R. Sormunen, Y. Soini, P. Paakko, T. Ollikainen, K. Kahlos, A. Hirvonen, and S. Knuutila Ultrastructural and Chromosomal Studies on Manganese Superoxide Dismutase in Malignant Mesothelioma Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 147 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Seike, T. Kondo, Y. Mori, A. Gemma, S. Kudoh, M. Sakamoto, T. Yamada, and S. Hirohashi Proteomic Analysis of Intestinal Epithelial Cells Expressing Stabilized {beta}-Catenin Cancer Res., August 1, 2003; 63(15): 4641 - 4647. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Kinnula and J. D. Crapo Superoxide Dismutases in the Lung and Human Lung Diseases Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1600 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Nelson, A. C. Ranganathan, J. Mansouri, A. M. Rodriguez, K. M. Providence, J. L. Rutter, K. Pumiglia, J. A. Bennett, and J. A. Melendez Elevated Sod2 Activity Augments Matrix Metalloproteinase Expression: Evidence for the Involvement of Endogenous Hydrogen Peroxide in Regulating Metastasis Clin. Cancer Res., January 1, 2003; 9(1): 424 - 432. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |